[CITATION][C] First approval of a complement C3 inhibitor opens up autoimmune and inflammatory opportunities.
A Mullard - Nature reviews. Drug Discovery, 2021 - europepmc.org
First approval of a complement C3 inhibitor opens up autoimmune and inflammatory
opportunities. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC
Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter Blog Tech blog
Developer Forum Europe PMC plus Search life-sciences literature (41,445,329 articles, preprints
and more) Search Advanced search Feedback This website requires cookies, and the limited
processing of your personal data in order to function. By using the site you are agreeing to this as …
opportunities. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC
Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter Blog Tech blog
Developer Forum Europe PMC plus Search life-sciences literature (41,445,329 articles, preprints
and more) Search Advanced search Feedback This website requires cookies, and the limited
processing of your personal data in order to function. By using the site you are agreeing to this as …